High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections
about
Treatment of Helicobacter pylori infection: Current and future insightsManaging gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario.High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study.Efficacy and safety of high dose dual therapy for Helicobacter pylori rescue therapy: A systematic review and meta-analysis.Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants.Treatment of Helicobacter pylori Infection 2015.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.Dexlansoprazole: delayed-release orally disintegrating tablets for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease and the maintenance of erosive esophagitis.The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease.Recent advances in Helicobacter pylori eradication.
P2860
Q26769707-F2992092-57E2-49C0-BC42-83E5BF8D91DCQ30278055-9238C2A1-2AB4-4D1C-8E43-5648C5EEE7C8Q33639114-C80BB3D0-E9CC-419B-87A8-880403E63D99Q35867229-16987145-7CF8-405C-BBA6-E3AE57847D41Q36098476-B1BC6D67-3042-477E-87F5-DBB41CF35E81Q36224538-3461B359-5CBD-4092-AFAB-9E8437CD779FQ37045762-C1A4DD88-0AC1-4649-9F08-AD27175A8151Q38540311-CB849D2F-2874-4CA9-A687-462A0482EE55Q38587356-55981917-47E7-4BA1-A2CB-03AA0DE314CAQ38723877-E0F174EE-4C6B-42E0-B071-ACC71D61C27FQ38825937-CCD45D40-4DB6-43A5-A65C-1DF01A43DEB6Q39137644-15E5AF19-2237-48A2-B3D1-83FC6A8D6350Q42090635-85004DE7-7857-46AD-A517-110149E98027
P2860
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High-dose extended-release lan ...... Helicobacter pylori infections
@ast
High-dose extended-release lan ...... Helicobacter pylori infections
@en
type
label
High-dose extended-release lan ...... Helicobacter pylori infections
@ast
High-dose extended-release lan ...... Helicobacter pylori infections
@en
prefLabel
High-dose extended-release lan ...... Helicobacter pylori infections
@ast
High-dose extended-release lan ...... Helicobacter pylori infections
@en
P2860
P356
P1433
P1476
High-dose extended-release lan ...... Helicobacter pylori infections
@en
P2093
Taraq A Attumi
P2860
P304
P356
10.1111/HEL.12126
P577
2014-04-03T00:00:00Z